Stockhub

Alzinova AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 05:4405:44, 16 August 2022‎ Paris talk contribs‎ 511 bytes +511‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden. == References and not..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Alzinova_AB’